Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000614994 | SCV000732054 | likely benign | not specified | 2017-02-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000625327 | SCV000744951 | benign | Mucopolysaccharidosis, MPS-III-D | 2015-09-21 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000625327 | SCV001095822 | benign | Mucopolysaccharidosis, MPS-III-D | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000675670 | SCV000801373 | likely benign | not provided | 2017-11-03 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000675670 | SCV001742900 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000614994 | SCV001921300 | benign | not specified | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001829732 | SCV002091726 | benign | Sanfilippo syndrome | 2019-09-25 | no assertion criteria provided | clinical testing |